Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
 | UCB | 3 | - | -0,12 % | |
| AB INBEV | 2 | 30 | -0,13 % | |
| GBL | 2 | 1 | -0,18 % | |
| ARGENX | 1 | 10 | +0,28 % | ||
| ELIA GROUP | 1 | 4 | -0,14 % | |
| KBC GROEP NV | 1 | 1 | -0,17 % | |
| MELEXIS | - | 4 | 0,00 % | |
| UMICORE | - | 2 | -0,06 % | |
| AGEAS | - | 1 | -0,15 % | |
| MONTEA | - | 1 | +0,55 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | GBL: GBL - Transactions on GBL shares 20-04-2026 | 1 | Euronext | ||
| Mo | Interview with Laurein Cornelissen, Team Lead Expertise Power Transformers at Elia | 3 | Transformers | ||
| Mo | BERNSTEIN RESEARCH stuft AB Inbev auf 'Outperform' | 500 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für AB Inbev von 83 auf 87 Euro angehoben und die Einstufung auf "Outperform" belassen. Trevor Stirling zog in einer... ► Artikel lesen | |
| Mo | UCB Proposes $650M Acquisition of Neurona Therapeutics | 5 | Contract Pharma | ||
| Mo | UCB to purchase Neurona and NRTX-1001 for $1.15bn | 1 | Pharmaceutical Technology | ||
| Mo | UCB cuts $1.15bn deal to buy epilepsy biotech Neurona | 4 | pharmaphorum | ||
| Mo | ARGENX SE - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Mo | Italy's private equity weekly roundup. News from BeBeez, Di Luccia & Partners, Banca Investis, Duke&Kay, Recordati, CVC, Groupe Bruxelles Lambert, Adia, Gic, Caisse de Depot et Placement du Quebec, and more | 5 | BeBeez | ||
| Mo | KBC Groep: Notification for bondholders of KBC IFIMA | 234 | GlobeNewswire (Europe) | Following document is available on www.kbc.com:
- 2025 financial report of KBC IFIMA
► Artikel lesen | |
| Mo | ANHEUSER-BUSCH INBEV SA/NV - Disclosure Made According to the Requirements of the Law of 2 May 2007 | 4 | SENS | ||
| Sa | Should Altria sell off its Anheuser-Bush InBev stake? It's complicated | 39 | Seeking Alpha | ||
| Sa | argenx SE: argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP | 4 | GlobeNewswire (USA) | ||
| Fr | UCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B | 2 | BioPharma Dive | ||
| Fr | Belgian pharma UCB to buy U.S.-based Neurona for up to $1.15B | 4 | Seeking Alpha | ||
| Fr | UCB übernimmt Neurona Therapeutics für bis zu 1,15 Milliarden US-Dollar | 2 | Investing.com Deutsch | ||
| Fr | UCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicine | 3 | FierceBiotech | ||
| Fr | UCB to acquire Neurona Therapeutics for up to $1.15 billion | 2 | Investing.com | ||
| Fr | UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science | 961 | PR Newswire | Acquisition builds on UCB's 30-year heritage and leadership as an innovator in epilepsy and accelerates entry into next generation disease-modifying therapies.
... ► Artikel lesen | |
| Fr | Umicore - Transparency notification by Amundi SA | 4 | GlobeNewswire (USA) | ||
| Fr | Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV | 281 | GlobeNewswire (Europe) | Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV
As the quorum required for the Extraordinary General Meeting of Shareholders of Wednesday 22 April... ► Artikel lesen |
1 2 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.